These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12969793)

  • 1. GSK-3beta phosphorylation and alteration of beta-catenin in hepatocellular carcinoma.
    Ban KC; Singh H; Krishnan R; Seow HF
    Cancer Lett; 2003 Sep; 199(2):201-8. PubMed ID: 12969793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes.
    Cui J; Zhou X; Liu Y; Tang Z; Romeih M
    J Gastroenterol Hepatol; 2003 Mar; 18(3):280-7. PubMed ID: 12603528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and exon 3 mutation of beta-catenin in human hepatocellular carcinoma].
    Jiao Y; Ban KC; Cao J; Yue HY; Luo Y; Su JJ
    Ai Zheng; 2007 Oct; 26(10):1085-9. PubMed ID: 17927878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.
    Ding Q; Xia W; Liu JC; Yang JY; Lee DF; Xia J; Bartholomeusz G; Li Y; Pan Y; Li Z; Bargou RC; Qin J; Lai CC; Tsai FJ; Tsai CH; Hung MC
    Mol Cell; 2005 Jul; 19(2):159-70. PubMed ID: 16039586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma.
    Ueta T; Ikeguchi M; Hirooka Y; Kaibara N; Terada T
    Oncol Rep; 2002; 9(6):1197-203. PubMed ID: 12375019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ; Chua MS; Wei W; So SK
    Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma.
    Cui J; Zhou X; Liu Y; Tang Z; Romeih M
    Chin Med J (Engl); 2003 Dec; 116(12):1885-92. PubMed ID: 14687479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
    Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
    Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the expression of beta-catenin in hepatocellular carcinoma in areas with high and low levels of exposure to aflatoxin B1.
    Chen Ban K; Singh H; Krishnan R; Fong Seow H
    J Surg Oncol; 2004 Jun; 86(3):157-63. PubMed ID: 15170655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
    Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
    Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.
    Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T
    Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma.
    Kondo Y; Kanai Y; Sakamoto M; Genda T; Mizokami M; Ueda R; Hirohashi S
    Jpn J Cancer Res; 1999 Dec; 90(12):1301-9. PubMed ID: 10665646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle-related kinase mediates viral-host signalling to promote hepatitis B virus-associated hepatocarcinogenesis.
    Yu Z; Gao YQ; Feng H; Lee YY; Li MS; Tian Y; Go MY; Yu DY; Cheung YS; Lai PB; Yu J; Wong VW; Sung JJ; Chan HL; Cheng AS
    Gut; 2014 Nov; 63(11):1793-804. PubMed ID: 24440987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling.
    Fan W; Du F; Liu X
    Eur J Pharmacol; 2019 May; 850():109-117. PubMed ID: 30710548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway.
    Chen Z; Tang J; Cai X; Huang Y; Gao Q; Liang L; Tian L; Yang Y; Zheng Y; Hu Y; Tang N
    Cancer Sci; 2016 Oct; 107(10):1380-1389. PubMed ID: 27420729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spindle and kinetochore-associated protein 2 facilitates the proliferation and invasion of hepatocellular carcinoma via the regulation of Wnt/β-catenin signaling.
    Jiang J; Xu B; Zheng Y; Guo X; Chen F
    Exp Cell Res; 2020 Oct; 395(1):112181. PubMed ID: 32682011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 and beta-catenin signaling pathway may affect GSK-3beta expression in hepatocellular carcinoma.
    Wang XH; Meng XW; Xing H; Qu B; Han MZ; Chen J; Fan YJ; Lu CQ; Lu ZW
    Hepatogastroenterology; 2011; 58(106):487-91. PubMed ID: 21661417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
    Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
    Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher Matrix Stiffness Upregulates Osteopontin Expression in Hepatocellular Carcinoma Cells Mediated by Integrin β1/GSK3β/β-Catenin Signaling Pathway.
    You Y; Zheng Q; Dong Y; Wang Y; Zhang L; Xue T; Xie X; Hu C; Wang Z; Chen R; Wang Y; Cui J; Ren Z
    PLoS One; 2015; 10(8):e0134243. PubMed ID: 26280346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.